Through two days the international conference of the Faculty of Pharmacy, MSA University shed light on many urgent health related topics. The conference title was “Pharmacists in frontlines: New challenges & innovative solutions”.

International keynote speakers have demonstrated important data and research that covered disease and patient wellbeing subjects.

The conference has reached very fruitful recommendations that can contribute to health research fields. These recommendations focused on the use of small interfering RNA (siRNA) as an innovative out of the box tool for treatment. It is aimed to deliver antiviral siRNA either directly using cytosol targeting bacterial toxin or indirectly by using exosomes.

Widespread use of antibiotics should be discouraged, as they may lead to higher bacterial resistance rates, which will impact the burden of diseases and deaths in a population during the COVID-19 pandemic and beyond.

Principles (IPC) and AMS need to be applied to the COVID-19 clinical management / decision making process in all healthcare settings.

It is also recommended to use Nanofibers as excellent nano formulations for targeting brain.

Bright future is waiting for AI as saving money & time in radiology based assisted diagnosis, genomics, drug prescription and drug interactions. Pharmacoeconomics and health economics open the gate for many job opportunities in academia, market research, epidemiology, data management, biostability and health care policy.

Monitoring of the safety of COVID-19 vaccines as the global pandemic requires continuous attention.

The trials for using new antiviral agents in influenza treatment is still an interest in virology due to resistance to previous antiviral agents. The concept of polypharmacology is of great value for medicinal chemists to apply in drug repurposing and repositioning in order to reach treatment in less time and cost for patient health.

All academics, researchers, industry professionals and students are welcomed to join us in this valuable gathering.

Prof. Dr. David M. Aronoff, MD is the Director of the Division of Infectious Diseases at the Vanderbilt University Medical Center.
Prof. Aronoff, has been highly involved in the diagnosis and clinical care of COVID-19. He has been a key communicator of public health measures during the pandemic, through frequent media appearances, educational activities across the region, and direct relationships with employers.
You can follow him on Twitter @DMAronoff.
Title: An update on the diagnosis & management of COVID-19

PD Dr Martin Frotscher, born 1966, studied chemistry at Saarland University, Saarbrücken (Germany).
He received his PhD in Medicinal Chemistry in 1997, in the group of Prof. Dr. R. W. Hartmann.
Having held positions in the pharmaceutical and chemical industry (Menarini, Florence (Italy) and Chemcon, Freiburg i. Br. (Germany)), Dr. Frotscher returned to Saarland University, pursuing his research in steroidogenic enzyme inhibition.
In 2018, Dr. Frotscher completed his habilitation and obtained the venia legendi in Pharmaceutical and Medicinal Chemistry
Title: "Polypharmacology: Multiple Ligands - A Challenge for the Medicinal Chemist"

Dr Simon Richardson is a cell biologist who has an interest in drug delivery. His PhD was conducted at the UCL School of Pharmacy and he was a postdoc in Iowa USA studying lysosome biogenesis before starting his own research group at Greenwich is 2007.
The focus of his research group is the use of synthetic proteins to manipulate endomembrane for the delivery of siRNA and gene editing machinery. This research focuses on viral disease, cancer and obesity.
Title: Antiviral siRNA Delivery Using Recombinant Proteins and Exosomes.

Dr. Katerina Lalatsa- is a Reader in Nanomedicines and MSc Medical Biotechnology course leader at the School of Pharmacy and Biomedical Sciences, University of Portsmouth (UK).
Her lab is focused on the engineering of peptide and polymer amphiphiles for drug delivery and tissue regeneration and on additive manufacture of nanomedicines.
Title: "Nanomedicines for Brain Diseases and Cancers".
 

Dr. Hazem E. Hassan, PhD, MS, RPh, FCP is an Associate Director at Regeneron Pharmaceutical Inc. and a fellow of the American College of Clinical Pharmacology (ACCP). He oversees a variety of programs including neuroscience, hematology and ophthalmology portfolios. Prior to joining Regeneron, Dr. Hassan served as a Clinical Pharmacologist at the FDA and as an Assistant Professor and Director of the Pharmacokinetics and Biopharmaceutics Lab at University of Maryland where he mentored several PhD students, postdocs and visiting scientists. Dr. Hassan also holds a position as an Associate Professor at Faculty of Pharmacy, Helwan University. He is currently serving on different capacities on several leadership committees of the AAPS, ACCP and ASCPT. He co-authored 45 articles, book chapter and 95 abstracts. His research was supported by several grants from the FDA, NIH and UMB. In recognition of his contributions, Dr. Hassan received several awards from the FDA, AAPS and UMB, and was featured in the CPT journal, Bioanalysis Journal and AAPS News magazine.
Title: “Baloxavir Marboxil: A Novel Antiviral Agent for Treatment of Uncomplicated Influenza”

Dr. Omar Abouelata-, MPH, PhD Technical Officer – Surveillance, Preparedness and Response WHO/WRO/Egypt Title: COVID 19 and AMR Common Challenges, Threats, Joint prevention and control activities
 

Dr. Hadeer Rostom was a principal contributor in issuing the “Good Pharmacovigilance Practice guidelines in Arab Countries” (GVP-Arab).
She played an important role in strengthening Pharmacovigilance practice in Egypt and integrating pharmacovigilance teaching in Academia. She supervised several pharmacovigilance research projects. Hadir is seen as a strategic pharmacovigilance figure in Egypt and the region.
Title: Safety monitoring for COVID-19 Vaccines

Prof. Dr. Rania Hathout, currently works as a Professor at the Faculty of Pharmacy, Ain Shams University. Prof. Dr. Rania, does research in Nanomedicine and Drug Delivery, Nanotechnology, Polymer Chemistry, Physical Chemistry and Chemoinformatics.
Her current project is 'Preparation of drug-loaded conducting polymers using electrochemical polymerization - Department of Chemistry and Materials Science Institute - Lancaster University - Lancaster - UK.
Title: " Machine Learning methods in drug delivery "

Dr. Hussien Azmy, is leading the Marketing, Medical, Training, Regulatory as well as the New Product and Product Portfolio Planning and Business Development in Egypt, Middle East and Africa
Title: “Rameda Pharmaceuticals: Providing Innovative Solutions to Meet Therapeutic Needs and Challenges”

Dr. Gihan Hamdy El-Sisi- Lecturer_Health Economics, Arab Academy for Science & Technology & Cairo University
Health Economics Certificate Scientific Committee, American University in Cairo
Founder and Former Head of Pharmacoeconomic Unit, CAPA, MoH, Egypt
Health Economics Consultant, World Health Organization EMR Office
Treasurer of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Egypt
Title: “Role of pharmacist in boosting health economy: new opportunities”
 

Dr. Islam Anan is leading Accsight offices in the Middle East and Africa for the 3 business units (Accsight HIS) Marketing Research, Market Access, HEOR and Real World Evidence Research, (Accsight PSP).
He is Course Instructor for Economic Evaluation in the Health Economics Diploma and lecturer of Pharmacoeconomics and Health Care Marketing
Title: “COVID-19 Wave preparedness plan”

Title: Intelligent Healthcare

Eng. Medhat is a core member in Huawei’s global Digital Transformation Office. He is a senior ICT and IoT global industry expert who has led successful projects and digital transformation initiatives with the major international ICT industry leaders and held various senior positions, managing global assignments in North America, MEA, and APAC.
Title: Intelligent Healthcare